We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HBAN:SIXHelvetia Baloise Holding AG Analysis

Data as of 2026-05-18 - not real-time

$15.41

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Huntington Bancshares is trading at $15.41, roughly 20% below its 52‑week high and well under the DCF‑derived fair value of $29.25, suggesting a sizable upside. Valuation metrics such as a trailing P/E of 11.9 versus the industry average of 16.5 and a price‑to‑book of 1.05 underscore the stock’s relative cheapness. Fundamentally, the bank delivered a 33.6% revenue surge year‑over‑year and posted a forward EPS of $1.90, driving the forward P/E down to 8.1, which points to strong earnings momentum. The dividend yield of 4.0% with a payout ratio under 50% indicates a sustainable income stream.
On the technical side, the 20‑day SMA sits just above the 50‑day SMA, while the RSI of 36 hints at mild oversold conditions, yet the MACD remains bearish and price is confined between a $15.17 support and $17.35 resistance. Volume is trending higher and the Fear & Greed Index reads “Extreme Greed,” reflecting bullish market sentiment that could accelerate price appreciation. Recent upgrades from analysts, including a raised price target to $18, reinforce the upside narrative, though the bearish MACD and proximity to support advise caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support
  • Bearish MACD signal
  • Increasing volume suggests potential bounce

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to peers
  • Strong revenue and EPS growth
  • Robust dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value implies ~28% upside
  • Consistent earnings expansion and credit performance
  • Stable dividend and low debt‑to‑equity profile

Key Metrics & Analysis

Financial Health

Revenue Growth33.60%
Profit Margin26.60%
P/E Ratio11.9
ROE8.39%
ROA0.90%
P/B Ratio1.1
Op. Cash Flow$2.5B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI36.9
Support$15.17
Resistance$17.35
MA 20$16.32
MA 50$16.02
MA 200$16.76
MACDBearish
VolumeIncreasing
Fear & Greed Index87.54

Valuation

Fair Value$29.25
Target Price$19.73
Upside/Downside28.06%
GradeUndervalued
TypeBlend
Dividend Yield4.02%

Risk Assessment

Beta1.04
Volatility24.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.